Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

409 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SELDI-TOF serum proteomics and breast cancer: which perspective?
Garrisi VM, Abbate I, Quaranta M, Mangia A, Tommasi S, Paradiso A. Garrisi VM, et al. Among authors: quaranta m. Expert Rev Proteomics. 2008 Dec;5(6):779-85. doi: 10.1586/14789450.5.6.779. Expert Rev Proteomics. 2008. PMID: 19086858 Review.
Proteomic profile in familial breast cancer patients.
Garrisi VM, Tommasi S, Facchiano A, Bongarzone I, De Bortoli M, Cremona M, Cafagna V, Abbate I, Tufaro A, Quaranta M, Paradiso A. Garrisi VM, et al. Among authors: quaranta m. Clin Biochem. 2013 Feb;46(3):259-65. doi: 10.1016/j.clinbiochem.2012.11.003. Epub 2012 Nov 13. Clin Biochem. 2013. PMID: 23159292
Circulating hTERT DNA in early breast cancer.
Divella R, Tommasi S, Lacalamita R, Daniele A, Abbate I, Garrisi VM, Savino E, Coviello M, Rubini V, Simone G, Paradiso A, Quaranta M. Divella R, et al. Among authors: quaranta m. Anticancer Res. 2009 Jul;29(7):2845-9. Anticancer Res. 2009. PMID: 19596972 Free article.
The Integrated Oncology Program of the Italian Ministry of Health. Analytical and clinical validation of new biomarkers for early diagnosis: network, resources, methodology, quality control, and data analysis.
Paradiso A, Mangia A, Orlando C, Verderio P, Belfiglio M, Marchetti A, Bertario L, Chiappetta G, Gion M, Tonini GP, Podo F, Vocaturo A, Silvestrini R, Romani M, Belloni E, Cavallo D, Ulivi P, Tommasi S, Steffan A, Russo A, Alessio M, Calistri D, Zancan M, Parrela P, Broggini M, Giuseppe A, Buttitta F, Finocchiaro G, Mazzocco K, Veronesi G, Landuzzi L, Benevolo M, Mariani L, De Marco F, Venuti A, Giannelli G, Quaranta M, Trojano V. Paradiso A, et al. Among authors: quaranta m. Int J Biol Markers. 2009 Jul-Sep;24(3):119-29. doi: 10.1177/172460080902400301. Int J Biol Markers. 2009. PMID: 19787622 Free article.
Clinical and prognostic role of circulating MMP-2 and its inhibitor TIMP-2 in HCC patients prior to and after trans-hepatic arterial chemo-embolization.
Daniele A, Divella R, Quaranta M, Mattioli V, Casamassima P, Paradiso A, Garrisi VM, Gadaleta CD, Gadaleta-Caldarola G, Savino E, Maci R, Bellizzi A, Fazio V. Daniele A, et al. Among authors: quaranta m. Clin Biochem. 2014 Feb;47(3):184-90. doi: 10.1016/j.clinbiochem.2013.11.022. Epub 2013 Dec 16. Clin Biochem. 2014. PMID: 24355694 Clinical Trial.
409 results